Schlickewei Carsten, Neumann Julie A, Yarar-Schlickewei Sinef, Riepenhof Helge, Valderrabano Victor, Frosch Karl-Heinz, Barg Alexej
Department of Trauma and Orthopaedic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20251 Hamburg, Germany.
Department of Orthopaedics, University of Utah, 590 Wakara Way, Salt Lake City, UT 84108, USA.
J Clin Med. 2022 Jul 4;11(13):3893. doi: 10.3390/jcm11133893.
Demineralized bone matrix (DBM) has been shown to have positive effects on union rates in many orthopedic subspecialties; however, minimal evidence exists about bone graft substitutes in foot and ankle surgery. The purpose of this study is to compare nonunion rates in arthroscopic ankle arthrodesis in patients receiving DBM with those without. We hypothesized DBM to be associated with a decreased risk of nonunion. This retrospective review includes 516 consecutive ankle arthrodesis cases from March 2002 to May 2016. Of these, 58 ankles (56 patients) that underwent primary arthroscopic ankle arthrodesis met the inclusion criteria, and 31 of these ankles received DBM, while 27 did not. Nonunion was assessed by clinical examination and routine postoperative radiographs. If nonunion was suspected, a computed tomography (CT) scan was performed. The primary outcome measure was nonunion rate. Secondary outcome measures included wound complications, return to operating room (OR), and rate of postoperative deep vein thrombosis (DVT) or pulmonary embolism (PE). From the study cases, 58 were available for final follow-up. The average age was 55.9 years (±17.4), and mean follow-up was 43.0 months (range 6.3-119.4). There was no difference in nonunion rate in patients who received DBM (4/31, 12.9%) versus those who did not (4/27, 14.8%) ( = 0.83). Similarly, when comparing the two groups, there were no statistically significant differences in superficial wound complications (6.5% vs. 3.7%, = 1.0) or rate of return to OR (29% or 0.037/person-years vs. 37% or 0.099/person-years; = 0.20). No major complications including deep wound infections, DVTs, or PEs occurred. This is the largest study to directly compare nonunion rates and complications for patients receiving DBM versus those who did not in primary arthroscopic ankle arthrodesis. No significant association was found between DBM usage and risk of nonunion, wound complications, return to OR, or postoperative DVT or PE development.
脱矿骨基质(DBM)已被证明在许多骨科亚专业中对骨愈合率有积极影响;然而,关于足踝外科中骨移植替代物的证据却很少。本研究的目的是比较接受DBM的患者与未接受DBM的患者在关节镜下踝关节融合术中的骨不连发生率。我们假设DBM与降低骨不连风险相关。这项回顾性研究纳入了2002年3月至2016年5月期间连续的516例踝关节融合术病例。其中,58例(56名患者)接受初次关节镜下踝关节融合术的踝关节符合纳入标准,其中31例踝关节接受了DBM,27例未接受。通过临床检查和术后常规X线片评估骨不连情况。如果怀疑有骨不连,则进行计算机断层扫描(CT)。主要观察指标是骨不连发生率。次要观察指标包括伤口并发症、再次手术率、术后深静脉血栓形成(DVT)或肺栓塞(PE)发生率。在研究病例中,58例可进行最终随访。平均年龄为55.9岁(±17.4),平均随访时间为43.0个月(范围6.3 - 119.4个月)。接受DBM的患者骨不连发生率(4/31,12.9%)与未接受DBM的患者(4/27, 14.8%)之间无差异(P = 0.83)。同样地比较两组时,浅表伤口并发症(6.5%对3.7%,P = 1.0)或再次手术率(2)9%或0.037/人年对37%或0.099/人年;P = 0.20)无统计学显著差异。未发生包括深部伤口感染、DVT或PE在内的重大并发症。这是直接比较接受DBM与未接受DBM的患者在初次关节镜下踝关节融合术中骨不连发生率和并发症的最大规模研究。未发现使用DBM与骨不连风险、伤口并发症、再次手术、术后DVT或PE发生之间存在显著关联。